Your browser doesn't support javascript.
loading
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.
Lelliott, Emily J; Mangiola, Stefano; Ramsbottom, Kelly M; Zethoven, Magnus; Lim, Lydia; Lau, Peter K H; Oliver, Amanda J; Martelotto, Luciano G; Kirby, Laura; Martin, Claire; Patel, Riyaben P; Slater, Alison; Cullinane, Carleen; Papenfuss, Anthony T; Haynes, Nicole M; McArthur, Grant A; Oliaro, Jane; Sheppard, Karen E.
Afiliação
  • Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Mangiola S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Ramsbottom KM; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Zethoven M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Lim L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Lau PKH; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Oliver AJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Martelotto LG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Kirby L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Martin C; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Patel RP; Single Cell Innovation Laboratory, The University of Melbourne, Parkville, Victoria, Australia.
  • Slater A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Cullinane C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Papenfuss AT; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Haynes NM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Oliaro J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Cancer Immunol Res ; 9(2): 136-146, 2021 02.
Article em En | MEDLINE | ID: mdl-33303574
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Quinase 4 Dependente de Ciclina / Imunoterapia / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Quinase 4 Dependente de Ciclina / Imunoterapia / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália